Recent findings suggest that a personalized approach to recommending CPAP machines to patients with obstructive sleep apnea ...

There's a significant overlap between the symptoms of obstructive sleep apnea and central sleep apnea. It's important not to try self-diagnosis — leave your diagnosis to the experts.

Topline results from a second phase 3 trial of AD109-an investigational oral therapy combining aroxybutynin and ...

Sleep apnea is a condition where breathing repeatedly stops or reduces during sleep, often due to airway obstruction. It ...

The possibility of a dementia diagnosis may have a new origin, according to a recent study from UC Irvine. Medical research ...

Around one billion people around the world suffer from obstructive sleep apnea. Although central sleep apnea isn’t as common, it’s more prevalent in those who suffer from other health conditions.

A new treatment you may hear about is Zepbound (tirzepatide). In December 2024, Zepbound became the first FDA-approved medicine for treating obstructive sleep apnea.

Obstructive sleep apnea may be underdiagnosed; only 3% of Canadians aged 18 years or older reported a formal diagnosis despite high rates of symptom reporting; 3 yet, high-quality prospective studies ...

Apnimed has scored another phase 3 knockout. The Massachusetts biotech’s daily pill for obstructive sleep apnea reduced the ...

OTTAWA — Obstructive sleep apnea, a condition most often associated with overweight adults, is becoming so common in children that researchers at CHEO have developed a screening tool that could ...

Obstructive Sleep Apnea Obstructive sleep apnea should be suspected in overweight middle aged adults who snore loudly and which can cause interruption of breathing for 10 seconds or more and this ...

Obstructive Sleep Apnea is the repeated blockage of the airway at night while people are sleeping. Snoring is the biggest indicator of a disease that can be most harmful for patients, where they ...